For Admin

  • HOME
  • BUSINESS
  • TECHNOLOGY
  • APPLICATION
  • PARTNERING
  • NEWS
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012〜
  • CONTACT

Shin Nippon Biomedical Laboratories, Ltd. Translational Research Business

Japanese

A Leading Company in Nasal Drug Delivery

  • HOME
  • BUSINESS
  • TECHNOLOGY
    • Platform Technology
    • Special Analysis
    • Publication
  • APPLICATION
    • Absorption
    • Vaccination
    • Nose-to-Brain
  • PARTNERING
  • NEWS
  • CONTACT
  • PRIVACY POLICY

Nasal Drug Delivery

SNBL’s nasal drug delivery platform is a proprietary system consisting of powder carrier technology and delivery device technology.

Widely Applicable Technology

For Absorption
For Vaccination
For Nose-to-Brain

Expertise in Nasal Delivery

3D Nasal Cast Model

preview
next

News

2014

December 24, 2014

Termination of License Agreement with Besins Healthcare for Nasal Progesterone

October 16, 2014

News Release: SNBL Nasal Delivery Technology in The 505(b)(2) Forum

August 13, 2014

Business Collaboration Letter of Intent Signed between SNBL and Sosei Group Corporation and Progress on Development of Novel Nasal Epinephrine Product

2022|2021|2020|2019|2018|2016|2015|2014|2013|2012〜

BACK
  • HOME
  • BUSINESS
  • TECHNOLOGY
  • APPLICATION
  • PARTNERING
  • NEWS
  • CONTACT
  • PRIVACY POLICY
Cookie Policy | Sitemap
© Shin Nippon Biomedical Laboratories, Ltd. All Rights Reserved.
Log out | Edit